Cancer nanomedicines: oversold or underappreciated?

Roy van der Meel, Twan Lammers, Wim E. Hennink

Research output: Contribution to journalEditorialAcademicpeer-review

53 Citations (Scopus)
1 Downloads (Pure)


Not available.
Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalExpert Opinion on Drug Delivery
Issue number1
Publication statusPublished - 2 Jan 2017
Externally publishedYes


  • Cancer nanomedicines
  • Clinical translation
  • Clinical trials
  • Combination treatment
  • Drug delivery
  • Drug targeting
  • EPR effect
  • Triggered release

Fingerprint Dive into the research topics of 'Cancer nanomedicines: oversold or underappreciated?'. Together they form a unique fingerprint.

  • Cite this